Lexaria Bioscience (LEXX) Total Debt Growth (3y) (2018 - 2022)

Lexaria Bioscience (LEXX) Total Debt Growth (3y) (2018 - 2022) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt Growth (3y) (Qtr)
1 Alterity Therapeutics 719,706.53 Bn 719,706.50 Bn - -
2 Belite Bio 55,800.00 Bn 55,800.00 Bn - -
3 Quantum Biopharma 18,182.30 Bn 18,182.29 Bn - -
4 Legend Biotech 3,154.00 Bn 3,153.71 Bn 242.10 Mn 6.94%
5 Akari Therapeutics 1,844.30 Bn 1,844.29 Bn - -
6 Evaxion A 1,567.96 Bn 1,567.94 Bn - -
7 Psyence Biomedical 251.43 Bn 251.42 Bn - -
8 Vertex Pharmaceuticals 112.56 Bn 105.31 Bn 2.59 Bn -
9 Abivax 94.37 Bn 94.37 Bn - -
10 Lexaria Bioscience 7.17 Mn 1.65 Mn 20,000.00 -

Historic Data

Download Data
DateValue
May 31, 2022 -27.79%
Nov 30, 2021 -28.80%
Aug 31, 2021 0.30%
May 31, 2021 -47.42%
Feb 28, 2021 233.13%
Nov 30, 2020 67.72%
Aug 31, 2020 -10.44%
May 31, 2020 98.63%
Feb 29, 2020 -82.18%
Nov 30, 2019 -53.65%
Aug 31, 2019 -47.45%
May 31, 2019 -56.60%
Feb 28, 2019 -71.32%
Nov 30, 2018 -41.41%
Aug 31, 2018 -29.11%
Feb 28, 2018 46.78%